Ligand validation:6T8E

XYP: beta-D-xylopyranose

XYP is a Ligand Of Interest in 6T8E designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6T8E_XYP_D_504	52%	55%	0.106	0.861	0.55	1.17	-	2	0	0	100%	1
6T8E_XYP_A_504	46%	48%	0.127	0.86	0.65	1.33	-	2	0	0	100%	1
6T8E_XYP_C_504	44%	54%	0.116	0.842	0.66	1.12	-	1	0	0	100%	1
6T8E_XYP_B_504	34%	53%	0.13	0.813	0.61	1.18	-	1	0	0	100%	1
6T8E_XYP_D_508	31%	51%	0.148	0.815	0.44	1.42	-	2	0	0	100%	1
6T8E_XYP_B_508	26%	31%	0.161	0.802	0.57	2.11	-	5	0	0	100%	1
6T8E_XYP_D_507	21%	53%	0.153	0.758	0.42	1.38	-	2	0	0	100%	1
5NH7_XYP_A_504	45%	53%	0.174	0.905	0.68	1.14	-	1	0	0	100%	1
5NH9_XYP_A_504	41%	54%	0.161	0.877	0.68	1.07	-	-	0	0	100%	1
5NH8_XYP_A_504	37%	61%	0.19	0.887	0.56	0.93	-	-	0	0	100%	1
5NHE_XYP_A_504	34%	55%	0.196	0.88	0.42	1.3	-	2	0	0	100%	1
5NHD_XYP_A_504	27%	54%	0.216	0.861	0.58	1.18	-	1	0	0	100%	1
1OD8_XYP_A_1311	100%	64%	0.047	0.992	0.75	0.64	-	-	0	0	100%	1
1V0M_XYP_A_1304	100%	71%	0.035	0.993	0.82	0.33	-	-	0	0	90%	1
8Y00_XYP_D_201	99%	28%	0.032	0.986	0.63	2.19	-	7	1	0	90%	1
2WYS_XYP_A_1001	99%	38%	0.052	0.983	0.69	1.7	-	4	3	0	100%	1
4PMY_XYP_A_401	99%	73%	0.051	0.979	0.49	0.57	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.